Hyperion Therapeutics Raises $60 Million

Hyperion Therapeutics, a San Francisco-based drug company focused on gastroenterology and hepatology, has raised $60 million in Series C funding. Bay City Capital and Panorama Capital co-led the round, and were joined by return backers Highland Capital Partners, New Enterprise Associates and Sofinnova Ventures. PRESS RELEASE Hyperion Therapeutics, a privately held specialty pharmaceutical company focused on […]

PEHUB Community

Join the 12505 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget